RET and thyroid gland papillary carcinoma: It has been related to genetic mutations of the rearranged during transfection (RET) gene and papillary thyroid cancer/rat sarcoma viral oncogene homolog/B-Raf murine sarcoma viral oncogene homolog B1 (PTC-RAS-BRAF) pathway, with the last altered in most patients.